Clinical Trials
2 trialsNCT05483400 2025-03-30
TIRACAN
University Medical Center Groningen
Phase 2 Recruiting
NCT05060003 2024-02-20
Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Washington University School of Medicine
Phase 2 Terminated